Panaxia Labs (Israel) Price Prediction
HROD Stock | 4,753 215.00 4.74% |
Oversold Vs Overbought
35
Oversold | Overbought |
Using Panaxia Labs hype-based prediction, you can estimate the value of Panaxia Labs Israel from the perspective of Panaxia Labs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Panaxia Labs to buy its stock at a price that has no basis in reality. In that case, they are not buying Panaxia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Panaxia Labs after-hype prediction price | ILA 4753.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Panaxia |
Panaxia Labs After-Hype Price Prediction Density Analysis
As far as predicting the price of Panaxia Labs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Panaxia Labs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Panaxia Labs, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Panaxia Labs Estimiated After-Hype Price Volatility
In the context of predicting Panaxia Labs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Panaxia Labs' historical news coverage. Panaxia Labs' after-hype downside and upside margins for the prediction period are 4,749 and 4,757, respectively. We have considered Panaxia Labs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Panaxia Labs is very steady at this time. Analysis and calculation of next after-hype price of Panaxia Labs Israel is based on 3 months time horizon.
Panaxia Labs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Panaxia Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Panaxia Labs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Panaxia Labs, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 3.97 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4,753 | 4,753 | 0.00 |
|
Panaxia Labs Hype Timeline
Panaxia Labs Israel is currently traded for 4,753on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Panaxia is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.04%. %. The volatility of related hype on Panaxia Labs is about 0.0%, with the expected price after the next announcement by competition of 4,753. The company recorded a loss per share of 0.26. Panaxia Labs Israel had not issued any dividends in recent years. The entity had a split on the 22nd of February 2010. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out Panaxia Labs Basic Forecasting Models to cross-verify your projections.Panaxia Labs Related Hype Analysis
Having access to credible news sources related to Panaxia Labs' direct competition is more important than ever and may enhance your ability to predict Panaxia Labs' future price movements. Getting to know how Panaxia Labs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Panaxia Labs may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
DCI | Direct Capital Investments | 0.00 | 0 per month | 0.00 | (0.04) | 12.50 | (14.54) | 53.61 | |
HROD | Panaxia Labs Israel | 0.00 | 0 per month | 0.00 | (0.02) | 6.60 | (7.01) | 17.67 | |
NZHT | Netz Hotels | 0.00 | 0 per month | 2.71 | 0.16 | 9.70 | (5.50) | 22.43 | |
ITYF | Itay Financial AA | 0.00 | 0 per month | 2.86 | 0.17 | 10.51 | (6.66) | 25.65 | |
ININ | Inter Industries | 0.00 | 0 per month | 2.86 | 0.06 | 4.84 | (4.06) | 16.22 | |
ELCO | Elco | 0.00 | 0 per month | 1.29 | 0.26 | 4.08 | (2.94) | 7.99 | |
CRMT | Carmit | 0.00 | 0 per month | 1.37 | 0.07 | 6.35 | (3.77) | 14.58 | |
BYAR | B Yair Building | 0.00 | 0 per month | 7.12 | 0.05 | 8.70 | (4.44) | 61.93 | |
FTAL | Fattal 1998 Holdings | 0.00 | 0 per month | 1.41 | 0.16 | 4.56 | (2.58) | 9.02 | |
CMDR | Computer Direct | 0.00 | 0 per month | 0.00 | 0.43 | 3.82 | (1.10) | 8.00 |
Panaxia Labs Additional Predictive Modules
Most predictive techniques to examine Panaxia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Panaxia using various technical indicators. When you analyze Panaxia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Panaxia Labs Predictive Indicators
The successful prediction of Panaxia Labs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Panaxia Labs Israel, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Panaxia Labs based on analysis of Panaxia Labs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Panaxia Labs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Panaxia Labs's related companies.
Story Coverage note for Panaxia Labs
The number of cover stories for Panaxia Labs depends on current market conditions and Panaxia Labs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Panaxia Labs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Panaxia Labs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Panaxia Stock analysis
When running Panaxia Labs' price analysis, check to measure Panaxia Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panaxia Labs is operating at the current time. Most of Panaxia Labs' value examination focuses on studying past and present price action to predict the probability of Panaxia Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panaxia Labs' price. Additionally, you may evaluate how the addition of Panaxia Labs to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |